A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System Data
Authors:
- 4 January 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (1) , e2034059
Abstract
The current approach to assess the quality of hypertension treatment in health care systems remains limited to dichotomous measures of blood pressure (BP) (ie, percentage of patients with a BP controlled below target) regardless of the recommended number and doses of medications. However, there is increasing evidence that intensifying treatment is associated with clinical benefit for older adults, either by increasing doses and starting new agents1-5 or by prescribing specific medication classes for their noncardiovascular benefits (eg, angiotensin-converting enzyme inhibitors for kidney protection).6 As our health care system responds by developing new guidelines and measures to promote lower BP goals, we need more refined tools to guide safe approaches to treatment intensification for older adults.Keywords
This publication has 49 references indexed in Scilit:
- Diagnosis and Treatment of Sleep Apnea in Patients’ Homes: The Rationale and Methods of the “GoToSleep” Randomized-Controlled TrialJournal of Clinical Sleep Medicine, 2012
- Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasiaClinical Interventions in Aging, 2011
- Barriers to and Determinants of Medication Adherence in Hypertension Management: Perspective of the Cohort Study of Medication Adherence Among Older AdultsMedical Clinics of North America, 2009
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Alfuzosin (10mg) Does Not Affect Blood Pressure in Young Healthy MenEuropean Urology, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderlyThe American Journal of Cardiology, 1987
- Indapamide A Review of its Pharmacodynamic Properties and Therapeutic Efficacy in HypertensionDrugs, 1984
- Pharmacokinetics and clinical pharmacology of indapamideAmerican Heart Journal, 1983